The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)
Clinical trial NCT05769049 · COMPLETED
Trial details
- NCT number
- NCT05769049
- Sponsor
- Jiangsu Rec-Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2023-12-06
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.